I believe that the ABSSI indication will be the fastest route to an approved indication for Brilacidin which would open the door for device coatings as you said. There is a reason most antibiotics start with the ABSSI indication and that Is because that trial format is very straightforward and relatively quick. All just my opinion of course.
